Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support

BACKGROUND: The glutamatergic modulator ketamine has been shown to result in rapid reductions in both suicidal ideation (SI) and depressive symptoms in clinical trials. There is a practical need for identification of pre-treatment predictors of ketamine response. Previous studies indicate links betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudequin, Denise, Can, Adem T., Dutton, Megan, Jones, Monique, Gallay, Cyrana, Schwenn, Paul, Yang, Cian, Forsyth, Grace, Simcock, Gabrielle, Hermens, Daniel F., Lagopoulos, Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594449/
https://www.ncbi.nlm.nih.gov/pubmed/33115424
http://dx.doi.org/10.1186/s12888-020-02925-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594449/
https://www.ncbi.nlm.nih.gov/pubmed/33115424
http://dx.doi.org/10.1186/s12888-020-02925-1

Ejemplares similares